Home › Funds › FINDELL CAPITAL MANAGEMENT LLC › ABVX

FINDELL CAPITAL MANAGEMENT LLC position in ABVX

ABIVAX SA · Health Care

FINDELL CAPITAL MANAGEMENT LLC reported holding 185,000 shares of ABVX (ABIVAX SA) in its Q2 2026 13F filing — a position valued at US$24.7M, representing 5.72% of its reported portfolio and ranking #6 among its reported holdings. FINDELL CAPITAL MANAGEMENT LLC has disclosed ABVX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)185.00K sh
Reported value held$24.65M
Portfolio Weight5.72%
First reportedQ3 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How FINDELL CAPITAL MANAGEMENT LLC's ABVX position evolved

FINDELL CAPITAL MANAGEMENT LLC first disclosed a stake in ABVX in Q3 2025 at 40,000 shares (US$3.4M). The position peaked in Q2 2026 at 185,000 shares, worth US$24.7M. Across 4 filings, FINDELL CAPITAL MANAGEMENT LLC increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 185,000 shares valued at US$24.7M — an increase of 80,000 shares quarter over quarter.. Notable position changes include a 119% increase in Q1 2026 (shares rose 20% over the following quarter), a 76% increase in Q2 2026 (shares fell 26% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 40.00K $3.40M New
Q4 2025 48.00K $6.47M Add
Q1 2026 105.00K $11.69M Add
Q2 2026 185.00K $24.65M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABVX and 13F data

ABVX (ABIVAX SA) is a Health Care company. 72 other funds we track also report a position in ABVX — the largest reported positions include TCG Crossover Management, LLC (US$800.6M), Helikon Investments Ltd (US$371.4M), Darwin Global Management, Ltd. (US$348.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABVX

All ABVX fund holders →

FAQ

How long has FINDELL CAPITAL MANAGEMENT LLC held ABVX?

FINDELL CAPITAL MANAGEMENT LLC has disclosed ABVX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is FINDELL CAPITAL MANAGEMENT LLC's current position in ABVX?

As of Q2 2026, FINDELL CAPITAL MANAGEMENT LLC holds 185.00K shares of ABVX (ABIVAX SA), valued at $24.65M, representing 5.72% of its reported portfolio and ranking #6.

Has FINDELL CAPITAL MANAGEMENT LLC been buying or selling ABVX?

In the latest 13F filing (Q2 2026), FINDELL CAPITAL MANAGEMENT LLC increased its position in ABVX. The position peaked in Q2 2026 at 185.00K shares.

Which other funds hold ABVX?

Other major institutional holders of ABVX include TCG Crossover Management, LLC, Helikon Investments Ltd, Darwin Global Management, Ltd., among 72 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.